BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1459 related articles for article (PubMed ID: 19382240)

  • 21. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
    Sun P; Yu H; Zhang WQ; Hu M; Lv R
    Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
    Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
    Ge YL; Zhang X; Zhang JY; Hou L; Tian RH
    Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis].
    Li K; Li MJ; He T; Zheng Z; Zheng XL; Qu BH; Wang Y; Duan X; Zheng YJ
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2386-90. PubMed ID: 20137690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
    Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
    Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting tumor growth of colorectal cancer by blocking the expression of vascular endothelial growth factor receptor 3 using interference vector-based RNA interference.
    Lui Z; Ma Q; Wang X; Zhang Y
    Int J Mol Med; 2010 Jan; 25(1):59-64. PubMed ID: 19956902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
    Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
    Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K
    Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
    Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
    Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
    Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
    Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of inhabitation of VEGF expression with RNA interference on lung cancer therapy].
    Zhang Y; Gu ZP; Zhou YA; Wang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):341-3, 347. PubMed ID: 19351507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
    Takei Y; Kadomatsu K; Yuzawa Y; Matsuo S; Muramatsu T
    Cancer Res; 2004 May; 64(10):3365-70. PubMed ID: 15150085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.